The Unmistakable Ivermectin Miracle In The Indian State Of Uttar Pradesh

Horowitz: The unmistakable ivermectin miracle in the Indian state of Uttar Pradesh

Daniel Horowitz

Uttar Pradesh might sound obscure to most Americans, but it is the most populated state in India, with urban areas that rival the most densely populated cities in the U.S. Yet, miraculously, despite housing a population of 240 million people, this northern state has been averaging only 24 cases and 0-2 deaths per day in recent months. Despite its size — roughly 73% of the U.S. population — it ranked dead last in cases per capita last week among India's 36 states. What gives? 

The answer likely lies in the 10-letter "I-word" that you are not allowed to mention on social media: ivermectin. Evidently, the global medical junta doesn't like the over 60 studies vouching for the efficacy of ivermectin against SARS-CoV-2, especially when used early, but there is something better than a study: pure reality of lived experience.

Last year, the northern state of Uttar Pradesh began dispensing ivermectin liberally and encouraging people to take it early on and even preventively. As Trial Site News reported earlier this year, "By the end of 2020, Uttar Pradesh — which distributed free ivermectin for home care — had the second-lowest fatality rate in India at 0.26 per 100,000 residents in December. Only the state of Bihar, with 128 million residents, was lower, and it, too, recommends ivermectin."

As you can see, COVID has been dead in Uttar Pradesh with the exception of a very brief six-week spike in the early spring. Uttar Pradesh likely would have been the first world experiment of what a given area would have looked like had they been taking ivermectin from day one before a wave hit. Unfortunately, hundreds of thousands of seasonal migrants fled Mumbai and other big cities when the Delta wave hit and all settled back in their villages in Uttar Pradesh, giving them the same spike that every other state got because those people were not on ivermectin. As the AP reported in mid-April, during the surge in Uttar Pradesh, many of these seasonal workers who work half the year in the big cities returned home to their villages. They were likely not taking ivermectin.

But when the state began distributing the drug to everyone, cases plummeted quicker and sharper than anywhere else we've seen in the world, and the gains have held for months with record low cases. Dr. Surya Kant Tripathi, head of the Respiratory Medicine Department, King George Medical University, Lucknow, told the Financial Express Online in April that the state began giving ivermectin to everyone who was in home isolation (rather than telling them to do nothing until they can't breathe, like we do here in the United States).

They also avoided use of the odious remdesivir. "All trials are saying that this drug is not effective in the treatment of COVID-19, rather it is complicating and resulting in mortality of patients," said Dr. Tripathi. "At so many centers, remdesivir trials were stopped. Also, remdesivir is costing minimum of Rs 5,000 per vial."

More...